Effect of Transarterial Imimmoembolization as Preoperative Treatment for Hepatocellular Carcinoma

Annals of Cancer Research and Therapy

Volumn 19, Issue 1, 2011, Pages 26-33

  Saito, Takuro ^a   Tsuchiya, Takao ^a   Sato, Yoshihiro ^a   Kenjo, Akira ^a   Kimura, Takashi ^a   Anazawa, Takayuki ^a   Terashima, Masanori ^a   Takahashi, Atsushi ^a   Ohira, Hiromasa ^a   Gotoh, Mitsukazu ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

hepatocellular carcinoma; immunotherapy; OK432; Transarterial immunoembolization

Indexed keywords

EID: 84964626253     PISSN: 13446835     EISSN: None     Source Type: Journal    
DOI: 10.4993/acrt.19.26     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, Pisani P. (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
2. Lencioni R (2010) Loco-regional treatment of hepatocellular carcinoma. Hepatology 52: 762-773.
3. th Annual Meeting of the Japan Society of Hepatology (2009). Hepatol Res 40: 667-685.
4. Wu CC, Cheng SB, Ho WM, Chen JT, Liu TJ, P'eng FK. (2005) Liver resection for hepatocellular carcinoma in patients with cirrhosis. Br J Surg 92: 348-355.
5. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. (1999) Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 229: 216-222.
6. Wu CC, Cheng SB, Yeh DC, Wang J, P'eng FK. (2009) Second and third hepatectomies for recurrent hepatocellular carcinoma are justified. Br J Surg 96: 1049-1057.
7. Rossi S, Ravetta V, Rosa L, Ghittoni G, Viera FT, Garbagnati F, Silini EM, Dionigi P, Calliada F, Quaretti P, Tinelli C. (2011) Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology 53: 136-47.
8. Tung-Ping Poon R, Fan ST, Wong J. (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232: 10-24.
9. Wada Y, Nakashima O, Kutami R, Yamamoto O, Kojiro M. (1998) Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology 27: 407-414.
10. Kawata A, Une Y, Hosokawa M, Uchino J, Kobayashi H. (1992) Tumor-infiltrating lymphocytes and prognosis of hepatocellular carcinoma. Jpn J Clin Oncol 22: 256-263.
11. Unitt E, Rushbrook SM, Marshall A, Davies S, Gibbs P, Morris LS, Coleman N, Alexander GJ. (2005) Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 41: 722-730.
12. Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, Tang ZY (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25: 2586-2593.
13. Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu YX, Wang FS. (2007) Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 132: 2328-2339.
14. Thornton AM, Shevach EM. (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188: 287-296.
15. Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH, Ziegler SF. (2003) Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 112: 1437-1443.
16. Okamoto H, Shoin S, Koshimura S, Shimizu R. (1967) Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci. Jpn J Microbiol 11: 323-326.
17. Sugimachi K, Maehara Y, Akazawa K, Kondo Y, Kunii Y, Kitamura M, Yamaoka H, Takahashi Y, Kito T, Katou M. (1994) Postoperative chemotherapy including intraperitoneal and intradermal administration of the streptococcal preparation OK-432 for patients with gastric cancer and peritoneal dissemination: a prospective randomized study. Cancer Chemother Pharmacol 33: 366-370.
18. Fujimoto T, Duda RB, Szilvasi A, Chen X, Mai M, O'Donnell MA. (1997) Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell dominant state. J Immunol 158: 5619-5626.
19. Kanai T, Monden M, Sakon M, Gotoh M, Umeshita K, Hasuike Y, Nakano H, Monden T, Murakami T, Nakamura H. (1994) New development of transarterial immunoembolization (TIE) for therapy of hepatocellular carcinoma with intrahepatic metastases. Cancer Chemother Pharmacol 33 Suppl: S48-S54.
20. Yoshida T, Sakon M, Umeshita K, Kanai T, Miyamoto A, Takeda T, Gotoh M, Nakamura H, Wakasa K, Monden M. (2001) Appraisal of transarterial immunoembolization for hepatocellular carcinoma: a clinicopathologic study. J Clin Gastroenterol 32: 59-65.
21. Wu CC, Ho YZ, Ho WL, Wu TC, Liu TJ, P'eng FK. (1995) Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 82: 122-126.
22. Yamasaki S, Hasegawa H, Kinoshita H, Furukawa M, Imaoka S, Takasaki K, Kakumoto Y, Saitsu H, Yamada R, Oosaki Y, Arii S, Okamoto E, Monden M, Ryu M, Kusano S, Kanematsu T, Ikeda K, Yamamoto M, Saoshiro T, Tsuzuki T. (1996) A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res 87: 206-211.
23. Samuel M, Chow PK, Chan Shih-Yen E, Machin D, Soo KC. (2009) Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database Syst Rev CD001199.
24. Ohno T, Hirashima N, Orito E, Hasegawa I, Fujiwara K, Itoh K, Ozasa A, Shinkai N, Tanaka Y, Kato T, Ueda R, Sakakibara K. (2007) Impaired cytotoxic T lymphocyte inductivity by dendritic cells derived from patients with hepatitis C virus-positive hepatocellular carcinoma. Hepatol Res 37: 276-285.
25. Nakamoto Y, Mizukoshi E, Tsuji H, Sakai Y, Kitahara M, Arai K, Yamashita T, Yokoyama K, Mukaida N, Matsushima K, Matsui O, Kaneko S. (2007) Combined therapy of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety. Clin Exp Immunol 147: 296-305.
26. Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, Shimada K, Sakamoto M, Hirohashi S, Ohashi Y, Kakizoe T. (2000) Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 356: 802-807.
27. Tsuda H, Oda T, Sakamoto M, Hirohashi S. (1992) Different pattern of chromosomal allele loss in multiple hepatocellular carcinoma as evidence of their multiclonal origin. Cancer Res 52: 1504-1509.
28. Takenaka K, Yamamoto K, Taketomi A, Itasaka H, Adachi E, Shirabe K, Nishizaki T, Yanaga K, Sugimachi K. (1993) Possible multicentric occurrence of hepatocellular carcinoma: a clinico-pathological study. Hepatology 19: 889-894.
29. Sakon M, Umeshita K, Nagano H, Eguchi H, Kishimoto S, Miyamoto A, Ohshima S, Dono K, Nakamori S, Gotoh M, Monden M. (2000) Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves. Arch Surg 135: 1456-1459.
30. Palucka K, Banchereau J. (1999) Dendritic cells: a link between innate and adaptive immunity. J Clin Immunol 19: 12-25.
31. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18: 767-811.
32. Pulendran B, Banchereau J, Maraskovsky E, Maliszewski C. (2001) Modulating the immune response with dendritic cells and their growth factors. Trends Immunol 22: 41-47.
33. Sanchez-Sanchez N, Riol-Blanco L, Rodriguez-Fernandez JL (2006) The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J Immunol 176: 5153-5159.
34. Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Hermine O, Tough DF, Kaveri SV. (2005) Modulation of dendritic cell maturation and function by B lymphocytes. J Immunol 175: 15-20.
35. Crittenden MR, Thanarajasingam U, Vile RG, Gough MJ. (2005) Intratumoral immunotherapy: using the tumour against itself. Immunology 114: 11-22.
36. Kanzaki N, Terashima M, Kashimura S, Hoshino M, Ohtani S, Matsuyama S, Hoshino Y, Kogure M, Oshibe I, Endo H, Saito T, Yaginuma H, Gotoh M, Ohto H. (2005) Understanding the response of dendritic cells to activation by streptococcal preparation OK-432. Anticancer Res 25 (6B): 4231-4238.